Related Experiment Video
Updated: Jun 16, 2025
07:49
Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
124
Evaluation indicators for access to cancer screening services: a scoping review
1Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Public Health
|August 17, 2024
Summary
This study reviewed 331 publications on cancer screening access, identifying key indicators. The findings will help develop a better system for evaluating cancer screening access and its availability.
Area of Science:
- Health Services Research
- Cancer Epidemiology
- Public Health
Background:
- Access to healthcare services, particularly cancer screening, is crucial for effective public health strategies.
- The International Agency for Research on Cancer (IARC) emphasizes 'availability' as a key indicator for cancer screening.
- Current methods for evaluating and reporting cancer screening access indicators are inconsistent, hindering evidence-based decision-making.
Purpose of the Study:
- To systematically identify and collate existing indicators used to evaluate access to cancer screening services.
- To understand the current application and gaps in the use of these indicators.
- To inform the development of a standardized evaluation system for cancer screening access.
Main Methods:
- A comprehensive scoping review of studies published between 2013 and 2022 was conducted.
- Indicators of access to cancer screening services were extracted and quantified.
- Extracted indicators were mapped to two established frameworks: the universal five-dimensional framework for healthcare access (U5D) and the IARC's cancer-specific framework.
Main Results:
- A total of 331 studies were included in the review.
- Analysis revealed various indicators across supply-side (e.g., approachability, availability) and demand-side (e.g., ability to perceive, seek, reach, pay) perspectives.
- IARC-endorsed indicators related to policy, screening type, coverage, and demographics were also identified, leading to the proposal of an integrated framework.
Conclusions:
- This review successfully identified and organized a wide range of indicators for assessing cancer screening access.
- Significant gaps in the current application of these indicators were determined.
- The findings provide a foundation for developing a robust and systematic indicator system to improve cancer screening evaluation and accessibility.
Related Concept Videos
01:21Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
01:30Preventive Healthcare Services
977
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
977
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
01:25Statistical Methods for Analyzing Epidemiological Data
336
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
336
01:20Comparing the Survival Analysis of Two or More Groups
164
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
164
01:12Hazard Ratio
103
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
103